GIANNOULIA, PANAGIOTA
GIANNOULIA, PANAGIOTA
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation
2014 Francesco De Rosa, Ilaria Iacobucci, Emanuela Ottaviani, Annalisa Astolfi, Annalisa Lonetti, Nicoletta Testoni, Tiziana Storlazzi, Luciana Impera, Simona Soverini, Stefania Paolini, Pier Paolo Piccaluga, Cristina Papayannidis, Panagiota Giannoulia, Daniela Cilloni, Andrea Pession, Fabrizio Pane, Antonella Vitale, Robin Foa, Michele Baccarani, Giovanni Martinelli
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors
2014 Ilaria Iacobucci, Emanuela Ottaviani, Annalisa Astolfi, Francesco De Rosa, Annalisa Lonetti, Nicoletta Testoni, Tiziana Storlazzi, Luciana Impera, Simona Soverini, Stefania Paolini, Pier Paolo Piccaluga, Cristina Papayannidis, Panagiota Giannoulia, Daniela Cilloni, Andrea Pession, Fabrizio Pane, Antonella Vitale, Robin Foa, Michele Baccarani, Giovanni Martinelli
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients
2014 Cristina Papayannidis, Ilaria Iacobucci, Simona Soverini, Stefania Paolini, Sandra Santucci, Daniela Cilloni, Francesca Messa, Fabrizio Pane, Vittorio Meneghini, Panagiota Giannoulia, Emanuela Ottaviani, Nicoletta Testoni, Barbara Lama, Maria Pantaleo, Michele Baccarani, Giovanni Martinelli
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors
2014 Ilaria Iacobucci, Annalisa Lonetti, Emanuela Ottaviani, Daniela Cilloni, Francesca Messa, Stefania Paolini, Cristina Papayannidis, Pier Paolo Piccaluga, Panagiota Giannoulia, Simona Soverini, Marilina Amabile, Giuseppe Saglio, Fabrizio Pane, Giorgio Berton, Anna Baruzzi, Antonella Vitale, Robin Foa, Michele Baccarani, Giovanni Martinelli
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib
2008 Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papayannidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M.
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
2007 Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G.
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia
2006 S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Rondoni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation | Francesco De Rosa, Ilaria Iacobucci, Emanuela Ottaviani, Annalisa Astolfi, Annalisa Lonetti, Nico...letta Testoni, Tiziana Storlazzi, Luciana Impera, Simona Soverini, Stefania Paolini, Pier Paolo Piccaluga, Cristina Papayannidis, Panagiota Giannoulia, Daniela Cilloni, Andrea Pession, Fabrizio Pane, Antonella Vitale, Robin Foa, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors | Ilaria Iacobucci, Emanuela Ottaviani, Annalisa Astolfi, Francesco De Rosa, Annalisa Lonetti, Nico...letta Testoni, Tiziana Storlazzi, Luciana Impera, Simona Soverini, Stefania Paolini, Pier Paolo Piccaluga, Cristina Papayannidis, Panagiota Giannoulia, Daniela Cilloni, Andrea Pession, Fabrizio Pane, Antonella Vitale, Robin Foa, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients | Cristina Papayannidis, Ilaria Iacobucci, Simona Soverini, Stefania Paolini, Sandra Santucci, Dani...ela Cilloni, Francesca Messa, Fabrizio Pane, Vittorio Meneghini, Panagiota Giannoulia, Emanuela Ottaviani, Nicoletta Testoni, Barbara Lama, Maria Pantaleo, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors | Ilaria Iacobucci, Annalisa Lonetti, Emanuela Ottaviani, Daniela Cilloni, Francesca Messa, Stefani...a Paolini, Cristina Papayannidis, Pier Paolo Piccaluga, Panagiota Giannoulia, Simona Soverini, Marilina Amabile, Giuseppe Saglio, Fabrizio Pane, Giorgio Berton, Anna Baruzzi, Antonella Vitale, Robin Foa, Michele Baccarani, Giovanni Martinelli | 2014-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib | Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papaya...nnidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 4.01 Contributo in Atti di convegno | - |
| Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain | Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga... PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia | S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Ron...doni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |